Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11136261 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  A Phase Ib Study of ISF35 in Combination With Chemotherapy (FCR) in Subjects With Relapsed, Refractory, and/or 17p- CLL
Condition: Chronic Lymphocytic Leukemia
Intervention: Biological: ISF35

Indicates status has not been verified in more than two years